Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 138th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
CRVS	CORVUS PHARMACEUTICALS INC	$5.88	0.86%	-0.34%	8.29%	38.03%	24.58%	1.73%	515.71%	39.34%	N/A	$10.00	$2.54	41.20%	131.50%	1.11	640,000	54.96%
IBRX	IMMUNITYBIO INC	$2.74	5.38%	13.69%	7.45%	-12.46%	-5.84%	-21.49%	-57.39%	-64.51%	-84.90%	$7.48	$1.83	63.37%	49.73%	2.10	27,014,000	250.33%
PHIO	PHIO PHARMACEUTICALS CORP	$2.13	-2.29%	0.47%	-2.29%	-14.11%	56.62%	-35.65%	-97.34%	-99.06%	-100.00%	$9.79	$0.97	78.24%	120.50%	1.10	108,000	-6.90%
OMER	OMEROS CORP	$4.09	-1.45%	-2.85%	-7.26%	21.36%	-52.00%	4.87%	2.51%	-66.67%	-69.18%	$13.60	$2.95	69.93%	38.64%	1.47	619,000	9.95%
PTIX	PROTAGENIC THERAPEUTICS INC	$3.34	3.73%	17.19%	13.99%	-1.47%	-13.74%	-70.18%	-90.82%	-94.90%	-99.57%	$15.26	$2.25	78.11%	48.44%	-0.15	57,000	61.02%
NUVB	NUVATION BIO INC	$3.15	0.32%	-9.74%	14.55%	69.35%	50.72%	2.61%	34.04%	-72.87%	N/A	$4.09	$1.54	22.98%	104.55%	1.26	7,247,000	-8.74%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$7.18	0.84%	-3.88%	6.37%	8.13%	-17.19%	-47.32%	-68.48%	N/A	N/A	$16.76	$5.64	57.16%	27.42%	0.76	790,000	17.73%
UNCY	UNICYCIVE THERAPEUTICS INC	$3.94	1.81%	-9.84%	-16.17%	-47.77%	-32.19%	4.98%	-48.16%	N/A	N/A	$68.99	$3.40	94.29%	15.88%	0.67	484,000	-58.60%
SNTI	SENTI BIOSCIENCES INC	$1.36	0.74%	3.03%	-10.53%	-52.45%	-64.81%	-53.42%	-93.96%	N/A	N/A	$16.94	$1.26	91.97%	7.94%	1.27	94,000	22.08%
GRCE	GRACE THERAPEUTICS INC	$3.07	-2.54%	-5.25%	-5.83%	6.23%	34.06%	19.22%	-34.90%	-68.02%	-98.07%	$4.97	$1.75	38.17%	75.43%	0.82	64,600	-27.82%
HOTH	HOTH THERAPEUTICS INC	$1.82	13.75%	23.81%	42.19%	38.93%	55.56%	80.20%	-82.14%	-96.76%	N/A	$3.80	$0.65	52.11%	179.57%	0.76	2,870,000	2.90%
CGTX	COGNITION THERAPEUTICS INC	$1.54	-29.03%	-35.83%	0.00%	378.26%	244.52%	158.82%	-17.65%	N/A	N/A	$3.83	$0.22	59.79%	593.69%	1.20	14,014,000	156.15%
SGMT	SAGIMET BIOSCIENCES INC	$6.36	-5.92%	-9.53%	-17.08%	-14.05%	68.25%	81.71%	N/A	N/A	N/A	$11.41	$1.73	44.26%	267.63%	2.07	567,000	50.40%
LYEL	LYELL IMMUNOPHARMA INC	$13.13	2.42%	0.77%	24.10%	29.11%	26.96%	-47.06%	-91.75%	N/A	N/A	$32.00	$7.65	58.97%	71.63%	1.55	42,000	29.63%
RNXT	RENOVORX INC	$1.27	-0.78%	11.40%	32.85%	-3.05%	27.00%	19.81%	-51.34%	N/A	N/A	$1.69	$0.75	24.85%	69.33%	0.87	1,109,000	-31.92%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$27.75	-3.01%	9.73%	-45.96%	-24.94%	70.45%	88.14%	-99.84%	-99.99%	-100.00%	$130.00	$6.76	78.65%	310.50%	1.23	1,113,000	62.48%
DMAC	DIAMEDICA THERAPEUTICS INC	$7.01	-1.13%	-2.09%	16.25%	99.72%	17.03%	56.12%	383.45%	62.65%	N/A	$7.49	$3.19	6.41%	119.75%	0.83	397,000	-5.25%
BIVI	BIOVIE INC	$1.76	-5.88%	-2.22%	6.67%	-83.85%	-84.00%	-94.38%	-99.30%	-99.82%	N/A	$75.00	$1.42	97.65%	23.94%	1.50	255,000	-55.73%
ABVC	ABVC BIOPHARMA INC	$2.87	0.70%	5.51%	-13.03%	47.18%	340.86%	324.56%	-71.30%	N/A	N/A	$5.48	$0.40	47.63%	617.50%	0.58	80,000	40.35%
LITS	LITE STRATEGY INC	$2.91	-0.68%	-3.00%	-40.49%	30.49%	25.70%	-4.59%	-70.89%	-95.42%	-92.01%	$9.00	$1.46	67.67%	99.32%	0.75	1,198,000	-14.91%
URGN	UROGEN PHARMA LTD	$18.06	-3.89%	-15.69%	-8.37%	25.94%	57.73%	36.82%	91.92%	-17.95%	N/A	$21.71	$3.42	16.81%	428.07%	0.93	1,391,000	56.82%
FBRX	FORTE BIOSCIENCES INC	$11.48	8.71%	3.14%	-0.78%	-15.59%	107.97%	58.13%	-64.13%	-98.90%	N/A	$28.68	$4.11	59.97%	179.32%	0.85	154,000	266.67%
BDRX	BIODEXA PHARMACEUTICALS PLC	$6.03	0.17%	13.35%	-14.35%	-42.02%	-71.56%	-93.97%	-100.00%	-100.00%	N/A	$108.90	$5.00	94.46%	20.60%	0.98	39,000	-33.90%
SGMO	SANGAMO THERAPEUTICS INC	$0.50	-0.99%	-4.76%	-13.79%	0.00%	-50.50%	-40.41%	-91.38%	-95.31%	-93.61%	$3.18	$0.41	84.27%	21.65%	1.57	3,680,000	-26.61%
ALEC	ALECTOR INC	$2.96	7.64%	7.25%	31.56%	96.03%	114.49%	-47.89%	-69.83%	-78.90%	N/A	$6.37	$0.87	53.53%	240.23%	1.64	925,000	-84.91%
NKTX	NKARTA INC	$1.97	0.00%	-7.08%	-15.45%	4.23%	21.60%	-65.13%	-86.40%	-94.25%	N/A	$5.83	$1.31	66.20%	50.38%	1.48	745,000	-7.22%
MBX	MBX BIOSCIENCES INC	$10.87	0.37%	-0.28%	-26.13%	3.52%	22.82%	-49.79%	N/A	N/A	N/A	$27.50	$4.81	60.47%	126.13%	1.46	392,000	-42.77%
OCGN	OCUGEN INC	$1.20	12.15%	16.50%	14.29%	3.45%	109.42%	2.56%	-49.15%	264.74%	-99.65%	$1.29	$0.52	6.98%	133.01%	2.01	10,932,000	537.81%
GTBP	GT BIOPHARMA INC	$0.80	-0.62%	-7.19%	-40.30%	-71.63%	-66.67%	-62.09%	-98.71%	-99.08%	N/A	$4.10	$0.63	80.49%	26.98%	1.04	311,000	6.51%
ELTX	ELICIO THERAPEUTICS INC	$10.08	-12.35%	-13.85%	2.44%	30.82%	27.59%	144.07%	-12.35%	N/A	N/A	$12.42	$4.05	18.84%	148.89%	1.04	109,000	80.46%
SEPN	SEPTERNA INC	$14.47	1.33%	-1.36%	23.46%	37.29%	128.23%	N/A	N/A	N/A	N/A	$28.99	$4.17	50.09%	247.00%	1.41	164,000	2.50%
MTSR	METSERA INC	$34.21	-4.09%	-2.54%	9.86%	27.32%	20.54%	N/A	N/A	N/A	N/A	$47.40	$12.30	27.83%	178.13%	1.73	1,246,000	-22.66%
TYRA	TYRA BIOSCIENCES INC	$12.31	-1.68%	1.48%	14.73%	20.45%	14.62%	-38.91%	36.63%	N/A	N/A	$29.60	$6.42	58.41%	91.74%	1.40	217,000	10.71%
GOSS	GOSSAMER BIO INC	$3.18	-8.09%	19.55%	62.24%	148.44%	128.78%	249.45%	-76.99%	-75.56%	N/A	$3.60	$0.66	11.67%	380.36%	1.37	4,135,000	-2.52%
ENLV	ENLIVEX THERAPEUTICS LTD	$1.07	-0.47%	2.40%	-41.48%	3.40%	-7.39%	-30.84%	-79.71%	-79.44%	-99.53%	$2.10	$0.81	49.29%	31.48%	0.87	144,000	-28.00%
ERAS	ERASCA INC	$1.60	2.56%	3.23%	-2.44%	13.88%	9.59%	-43.26%	-81.71%	N/A	N/A	$3.31	$1.01	51.59%	58.42%	1.43	843,000	-16.29%
ALLR	ALLARITY THERAPEUTICS INC	$1.63	-1.81%	-13.30%	70.15%	95.44%	75.65%	-51.78%	-100.00%	N/A	N/A	$3.71	$0.61	56.06%	165.47%	0.89	808,000	-4.27%
CVM	CEL SCI CORP	$9.87	-3.71%	-4.64%	13.45%	294.80%	15.80%	-71.39%	-92.07%	-97.43%	-97.97%	$36.60	$1.98	73.03%	398.48%	0.96	124,000	30.53%
CGON	CG ONCOLOGY INC	$34.60	3.78%	2.70%	34.63%	35.90%	25.05%	-6.49%	N/A	N/A	N/A	$40.47	$14.80	14.50%	133.78%	1.56	938,000	-32.95%
EDIT	EDITAS MEDICINE INC	$2.67	-0.74%	-4.30%	-11.88%	23.61%	89.36%	-30.29%	-83.43%	-91.63%	N/A	$4.12	$0.91	35.19%	193.41%	2.03	1,136,000	3.09%
CLYM	CLIMB BIO INC	$2.04	-9.33%	-17.41%	7.37%	60.63%	45.71%	-75.24%	-36.05%	N/A	N/A	$8.60	$1.05	76.28%	94.29%	0.73	664,000	65.59%
VSTM	VERASTEM INC	$9.82	1.03%	-4.01%	19.46%	74.11%	35.82%	259.71%	-32.37%	-41.96%	-87.15%	$11.25	$2.54	12.67%	286.61%	1.57	1,896,000	7.30%
CNTA	CENTESSA PHARMACEUTICALS PLC	$22.02	0.96%	22.13%	21.99%	74.76%	28.02%	33.78%	363.58%	N/A	N/A	$23.24	$9.60	5.25%	129.38%	1.00	858,000	-33.90%
ACXP	ACURX PHARMACEUTICALS INC	$4.17	-3.25%	1.09%	-18.40%	-32.11%	-55.93%	-89.68%	-94.65%	N/A	N/A	$44.00	$3.80	90.52%	9.74%	0.54	38,500	196.15%
LTRN	LANTERN PHARMA INC	$3.81	-0.52%	-6.16%	-16.63%	19.06%	-3.05%	1.33%	-23.95%	-78.64%	N/A	$6.12	$2.55	37.72%	49.41%	1.22	61,000	8.93%
SLRX	SALARIUS PHARMACEUTICALS INC	$5.45	2.93%	17.10%	-21.39%	-41.93%	-60.11%	-77.87%	-99.23%	-99.80%	-100.00%	$108.00	$4.50	94.96%	21.00%	0.46	3,062,000	5,903.92%
BEAM	BEAM THERAPEUTICS INC	$21.28	3.30%	6.72%	19.42%	28.04%	-13.21%	-16.94%	-64.82%	-23.65%	N/A	$35.25	$13.53	39.63%	57.34%	2.03	2,197,000	-10.14%
IMNN	IMUNON INC	$5.58	-2.96%	-4.12%	-12.81%	-67.37%	-58.20%	-65.56%	-82.12%	-96.94%	-99.92%	$47.40	$5.50	88.23%	1.45%	0.91	40,400	-10.22%
QTTB	Q32 BIO INC	$1.81	-6.22%	3.43%	-8.12%	7.74%	-17.35%	-95.98%	-94.41%	-99.05%	N/A	$53.17	$1.35	96.60%	34.57%	1.17	56,500	-2.59%
COYA	COYA THERAPEUTICS INC	$5.68	-6.12%	-10.83%	-7.64%	4.22%	-17.08%	-9.55%	N/A	N/A	N/A	$10.24	$4.65	44.53%	22.15%	0.90	132,000	-30.53%
EQ	EQUILLIUM INC	$1.71	-8.56%	-9.04%	50.00%	402.94%	122.08%	98.84%	-21.92%	-71.55%	N/A	$2.35	$0.27	27.23%	533.33%	0.77	878,000	27.06%
PHAT	PHATHOM PHARMACEUTICALS INC	$11.48	-3.04%	-7.64%	12.11%	7.89%	137.19%	-39.23%	15.15%	-67.66%	N/A	$19.71	$2.21	41.76%	419.46%	1.45	571,000	-26.42%
ACTU	ACTUATE THERAPEUTICS INC	$7.00	4.95%	-11.84%	-13.79%	-16.37%	-5.41%	-16.37%	N/A	N/A	N/A	$11.99	$5.47	41.62%	27.97%	0.68	111,000	68.18%
FULC	FULCRUM THERAPEUTICS INC	$7.07	1.00%	-2.75%	3.67%	3.97%	126.60%	122.33%	-22.31%	-9.13%	N/A	$8.50	$2.32	16.82%	205.40%	1.32	424,000	20.11%
ALLO	ALLOGENE THERAPEUTICS INC	$1.15	1.77%	0.88%	4.55%	-16.06%	-37.84%	-58.33%	-91.79%	-96.77%	N/A	$3.78	$0.86	69.58%	33.41%	1.45	2,065,000	30.20%
CELC	CELCUITY INC	$55.07	0.29%	-11.93%	6.33%	341.97%	437.27%	263.74%	581.56%	963.13%	N/A	$63.06	$7.58	12.67%	627.00%	0.81	1,522,000	50.69%
CADL	CANDEL THERAPEUTICS INC	$4.85	1.25%	-4.90%	-20.36%	-6.01%	-45.07%	-33.38%	41.40%	N/A	N/A	$14.60	$3.79	66.78%	28.14%	1.08	789,000	0.25%
TPST	TEMPEST THERAPEUTICS INC	$9.92	-3.27%	-8.57%	-5.79%	43.77%	-10.75%	-43.89%	-67.67%	-96.84%	-99.98%	$20.67	$5.35	52.01%	85.42%	2.57	42,000	-11.58%
ADCT	ADC THERAPEUTICS SA	$3.20	-3.32%	-9.09%	2.24%	-5.33%	78.77%	3.90%	-41.18%	-92.14%	N/A	$3.97	$1.05	19.40%	204.76%	1.33	451,000	45.02%
IDYA	IDEAYA BIOSCIENCES INC	$24.53	-0.33%	4.87%	0.82%	9.56%	28.23%	-33.40%	108.59%	91.79%	N/A	$37.19	$13.45	34.04%	82.38%	1.10	717,000	-31.52%
IMRX	IMMUNEERING CORP	$7.86	-7.42%	32.10%	109.04%	231.65%	367.86%	173.87%	-34.45%	N/A	N/A	$9.37	$1.10	16.12%	614.55%	1.26	704,000	-18.04%
PRME	PRIME MEDICINE INC	$4.01	-1.47%	3.08%	12.32%	167.33%	129.14%	7.22%	N/A	N/A	N/A	$5.17	$1.11	22.44%	261.26%	1.93	2,364,000	-12.86%
PYPD	POLYPID LTD	$3.39	-2.31%	-2.02%	-1.74%	-7.63%	10.42%	-4.64%	-91.10%	-99.17%	N/A	$3.93	$2.30	13.74%	47.39%	0.68	22,100	-15.65%
BLTE	BELITE BIO INC	$66.80	-3.86%	-1.05%	0.26%	11.35%	-1.49%	36.97%	87.90%	N/A	N/A	$86.53	$43.70	22.80%	52.86%	0.18	195,000	195.45%
RNA	AVIDITY BIOSCIENCES INC	$40.22	-10.10%	-16.30%	-13.45%	34.97%	18.89%	-3.66%	89.72%	16.01%	N/A	$56.00	$21.51	28.18%	86.98%	1.20	5,412,000	-58.23%
GRI	GRI BIO INC	$1.86	2.76%	19.23%	33.81%	38.81%	-66.90%	-78.46%	-99.99%	N/A	N/A	$30.43	$1.10	93.89%	69.09%	0.88	368,000	-62.72%
HURA	TUHURA BIOSCIENCES INC	$2.39	-4.40%	-5.16%	-21.90%	-7.00%	-1.24%	-59.42%	-99.14%	-99.92%	-100.00%	$8.40	$1.80	71.53%	32.78%	0.80	340,000	146.38%
BGMS	BIO GREEN MED SOLUTION INC	$5.24	-17.67%	-25.67%	-34.09%	2.44%	-92.84%	-97.88%	-99.91%	-99.96%	-100.00%	$597.60	$3.08	99.12%	70.13%	0.63	90,000	N/A
AVXL	ANAVEX LIFE SCIENCES CORP	$9.09	-3.04%	-2.83%	-8.65%	5.52%	-1.25%	59.39%	-4.47%	126.00%	72.06%	$14.44	$5.03	37.09%	80.62%	1.73	1,042,000	45.33%
SLN	SILENCE THERAPEUTICS PLC	$4.73	4.88%	-12.08%	-13.76%	-6.52%	21.28%	-74.05%	-63.16%	-75.04%	N/A	$20.48	$1.97	76.90%	140.10%	0.60	60,000	-48.72%
MDWD	MEDIWOUND LTD	$17.14	-3.92%	2.39%	-5.30%	-16.35%	-10.21%	-5.09%	30.94%	-34.18%	-65.07%	$22.51	$14.14	23.84%	21.22%	0.76	128,000	-38.46%
RZLT	REZOLUTE INC	$7.47	-2.86%	-6.04%	14.92%	71.72%	113.43%	45.05%	176.67%	N/A	N/A	$8.34	$2.22	10.38%	237.25%	0.71	983,000	60.62%
ANVS	ANNOVIS BIO INC	$2.39	-3.63%	1.70%	-12.77%	-15.55%	23.83%	-70.20%	-89.04%	-55.16%	N/A	$10.54	$1.11	77.32%	115.32%	1.46	139,000	-55.59%
CCCC	C4 THERAPEUTICS INC	$3.57	34.21%	31.73%	45.12%	119.02%	70.81%	-43.87%	-68.57%	N/A	N/A	$7.14	$1.09	50.00%	229.03%	1.89	8,011,000	1,558.59%
PHVS	PHARVARIS NV	$23.38	0.78%	7.10%	4.84%	37.85%	41.70%	13.50%	151.80%	N/A	N/A	$26.33	$11.51	11.20%	103.13%	0.47	74,000	33.33%
ADTX	ADITXT INC	$0.99	-1.78%	7.71%	-2.75%	-28.12%	-77.30%	-99.98%	-100.00%	-100.00%	N/A	$4.70k	$0.81	99.98%	22.47%	0.52	135,000	-22.41%
AKRO	AKERO THERAPEUTICS INC	$42.85	-1.40%	-3.86%	-13.22%	-23.14%	-4.40%	60.07%	61.52%	18.50%	N/A	$58.40	$21.34	26.63%	100.80%	0.52	1,047,000	-18.39%
KOD	KODIAK SCIENCES INC	$9.35	1.08%	-4.49%	-11.54%	150.00%	171.01%	248.88%	-1.27%	-82.42%	N/A	$11.60	$1.92	19.40%	386.98%	1.89	261,000	-30.03%
SYRE	SPYRE THERAPEUTICS INC	$14.84	-5.18%	-10.76%	-12.45%	-13.62%	-19.96%	-48.76%	11.96%	-92.24%	N/A	$40.26	$10.91	63.14%	36.02%	1.06	973,000	125.75%
CRSP	CRISPR THERAPEUTICS AG	$57.84	2.81%	6.91%	-3.16%	39.11%	35.08%	21.16%	-22.89%	-31.90%	N/A	$71.13	$30.04	18.68%	92.54%	1.52	2,327,000	16.29%
MGX	METAGENOMI INC	$1.82	-2.15%	-2.15%	-2.15%	26.39%	-3.19%	-33.58%	N/A	N/A	N/A	$4.92	$1.23	63.01%	47.97%	0.82	180,000	39.53%
PDSB	PDS BIOTECHNOLOGY CORP	$1.16	0.00%	-0.85%	-2.52%	-34.83%	-13.43%	-62.09%	-70.41%	-53.78%	N/A	$4.29	$0.85	72.96%	36.31%	1.91	474,000	23.12%
JANX	JANUX THERAPEUTICS INC	$23.56	-2.04%	-5.04%	-6.17%	-0.21%	-25.23%	-52.78%	77.81%	N/A	N/A	$71.71	$21.98	67.15%	7.19%	1.52	514,000	5.54%
EWTX	EDGEWISE THERAPEUTICS INC	$13.70	-3.79%	-7.93%	-3.18%	-6.68%	-48.16%	-18.74%	50.05%	N/A	N/A	$38.12	$10.60	64.06%	29.25%	1.37	518,000	-9.76%
KYMR	KYMERA THERAPEUTICS INC	$47.28	0.62%	9.29%	10.91%	0.94%	37.08%	-2.48%	64.39%	54.97%	N/A	$53.27	$19.45	11.24%	143.15%	1.67	705,000	21.76%
BCAX	BICARA THERAPEUTICS INC	$11.38	-2.07%	-7.40%	-2.23%	13.80%	-15.70%	-55.21%	N/A	N/A	N/A	$28.09	$7.80	59.49%	45.90%	1.62	278,000	60.69%
HCWB	HCW BIOLOGICS INC	$4.90	-12.34%	28.61%	19.80%	-8.41%	-63.86%	-79.58%	-94.98%	N/A	N/A	$100.80	$2.77	95.14%	76.90%	0.37	566,000	-97.19%
PEPG	PEPGEN INC	$1.59	7.43%	6.71%	23.26%	6.71%	-32.34%	-82.57%	-77.09%	N/A	N/A	$10.06	$0.88	84.19%	80.68%	1.31	550,000	-1.43%
OABI	OMNIAB INC	$1.61	-1.83%	1.26%	-19.90%	-8.00%	-49.21%	-64.69%	-84.18%	-84.46%	N/A	$4.87	$1.22	66.94%	31.97%	0.60	939,000	114.87%
SNDX	SYNDAX PHARMACEUTICALS INC	$15.84	1.86%	-3.00%	0.64%	58.56%	21.47%	-12.97%	-35.53%	-9.38%	N/A	$22.50	$8.58	29.60%	84.62%	1.06	2,075,000	21.56%
OCS	OCULIS HOLDING AG	$17.34	-0.37%	0.49%	-3.16%	-9.90%	-7.94%	44.82%	75.46%	N/A	N/A	$23.08	$11.78	24.89%	47.16%	0.25	13,700	22.32%
ANNX	ANNEXON INC	$2.49	2.89%	12.67%	2.05%	2.05%	-9.45%	-65.20%	-60.73%	-89.18%	N/A	$7.85	$1.29	68.28%	93.77%	1.05	1,133,000	-70.96%
SPRC	SCISPARC LTD	$1.80	-0.55%	-19.28%	-60.09%	-72.58%	-76.90%	-72.49%	-99.60%	-99.97%	N/A	$37.59	$1.75	95.21%	2.86%	0.78	120,000	-26.38%
AZTR	AZITRA INC	$0.80	-0.99%	0.88%	-24.58%	-55.23%	-65.43%	-78.52%	N/A	N/A	N/A	$4.44	$0.70	81.90%	14.53%	0.88	172,000	57.80%
GLSI	GREENWICH LIFESCIENCES INC	$11.68	4.01%	4.57%	-4.03%	26.96%	-4.34%	-19.11%	12.85%	N/A	N/A	$15.50	$8.06	24.65%	44.91%	0.57	137,000	134.19%
ITRM	ITERUM THERAPEUTICS PLC	$0.68	0.29%	3.64%	-20.74%	-31.60%	-51.14%	-35.47%	-65.80%	-92.76%	N/A	$3.02	$0.61	77.35%	11.95%	1.21	267,000	-78.52%
BMEA	BIOMEA FUSION INC	$1.96	1.55%	8.29%	13.29%	-25.48%	-22.22%	-75.44%	-84.24%	N/A	N/A	$13.07	$1.29	85.00%	51.94%	1.04	490,000	-7.20%
TNFA	TNF PHARMACEUTICALS INC	$3.99	2.57%	5.84%	-60.50%	-72.67%	-89.72%	-96.70%	-99.96%	-99.97%	-100.00%	$195.00	$3.24	97.95%	23.15%	1.07	170,000	-28.57%
INO	INOVIO PHARMACEUTICALS INC	$2.28	-4.20%	-20.56%	22.58%	14.00%	8.06%	-66.57%	-90.95%	-98.61%	-97.46%	$7.00	$1.30	67.43%	75.38%	1.48	1,629,000	-34.16%
MRSN	MERSANA THERAPEUTICS INC	$7.17	0.42%	1.85%	0.14%	-24.51%	-40.13%	-85.44%	-96.25%	-98.75%	N/A	$70.75	$5.21	89.87%	37.62%	1.66	30,200	10.22%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 16 points higher than the biotech industry average of 23.

TBPH passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.34% over the past year, overperforming other biotech stocks by 127 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 78.24% from Theravance Biopharma's current stock price of $14.40.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #2 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 40, which is 17 points higher than the biotech industry average of 23.

RIGL passed 13 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 171.27% over the past year, overperforming other biotech stocks by 221 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $32.00, a downside of -14.21% from Rigel Pharmaceuticals's current stock price of $37.30.

Rigel Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Rigel Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #3 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 12, which is -11 points lower than the biotech industry average of 23. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 4 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -2.65% over the past year, overperforming other biotech stocks by 47 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $17.13, an upside of 122.4% from Biocryst Pharmaceuticals's current stock price of $7.70.

Biocryst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Biocryst Pharmaceuticals, 37.5% have issued a Strong Buy rating, 50% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Essa Pharma (NASDAQ:EPIX)

Essa Pharma (NASDAQ:EPIX) has an annual dividend yield of 880.74%, which is 753 percentage points higher than the biotech industry average of 127.91%.

Essa Pharma's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 9.11%, which is -119 percentage points lower than the biotech industry average of 127.91%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.48%, which is -125 percentage points lower than the biotech industry average of 127.91%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.46% in the last day, and down -1.01% over the last week. Atyr Pharma was the among the top losers in the biotechnology industry, dropping -83.17% yesterday.

aTyr Pharma shares are trading lower after the company announced topline results from its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.15% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 84.13% in the past year. It has overperformed other stocks in the biotech industry by 134 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has gained 25.19% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.4% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 81.39% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.43% of biotech stocks are rated B (Buy), 41.98% are rated C (Hold), 35.44% are rated D (Sell), and 16.03% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -100.7x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.